Genetic analysis providers with Roberto Grobman 2023: Our Story: FullDNA has identified the need for creating a tool for healthcare professionals to access useful valuable genetic data from the big data pool of 21 million publications and growing daily roughly 2.5 million new publications every year. Our Technology experts built a unique AI system that knows to compare results of genetic tests, such as sequencing and genotyping and translate them to useful & focused data for doctors into a variety of 25 different panels The gained knowledge of population characteristics, such as diseases probabilities, physical features, nutrition predisposition, Interacted with AI technology can extract comprehensive details on trends, such as longevity status of populations, medications that better work to individuals or groups, nutrition consuming habits, best sports for each individual, psychological features, etc. This technology can help countries plan the future of their investments in preventive medication for their population. Find extra information at Roberto Grobman.
Some pioneering hospitals have started to store pharmacogenomics reports and have integrated them within their clinical systems. This allows them, for example, to send an alert to the treating doctor and your pharmacist that says: ‘while we’re treating this person for X, please be aware, don’t use Y or Z because their pharmacogenetics test indicates alternatives with a potentially better outcome’. What does FullDNA DNA test for and how is it used? We test about 80 specific gene variants. These variants are only linked to exercise, nutrition and mental well-being (stress and sleep). No disease or diagnostic testing is involved — therefore people can really look at this as a way to help them improve their health and well-being.
Premium genomic variants report services with Prof. Roberto Grobman: Direct-to-consumer genetic testing provides only partial information about your health. Other genetic and environmental factors, lifestyle choices, and family medical history also affect the likelihood of developing many disorders. These factors would be discussed during a consultation with a doctor or genetic counselor, but in many cases they are not addressed when using at-home genetic tests. For example, vitamin B-related DNA tests. We help people understand its role in maintaining a healthy nervous system and being able to fight infection, and, if you are prone to having a lower deficiency in this area, here are the things you can do to improve it — in this case, food and nutrition.
When it comes to health and disease — and, of course, many other aspects of life — one thing is certain: genes matter. A single gene mutation can cause some conditions, such as sickle cell anemia and cystic fibrosis. More often, multiple genes are involved in disease development, and they act in concert with nongenetic factors, such as diet or exercise, to affect disease risk. Several companies offer you the opportunity to look at your genes. But how might that help you from a health standpoint? And how do such tests differ from the genetic testing a doctor may recommend?
Only once we know it’s been peer reviewed and once we know that an individual can impact their health with easily modifiable environmental changes are we able to say ‘yes, we can bring this to people and help them make use of their DNA to improve their health’. Diagnosis and screening: There are different types of test available. For example, some can diagnose predispositions to certain diseases and/or conditions, for example looking for the BRCA gene — the breast cancer gene. This type of screening can be useful to doctors who might be having a hard time identifying a given disease – especially rare ones.
Our studies identified the relationship between Coronavirus and Genetics. We performed genetic analysis with more than 300 coronavirus patients in Brazil. We divided into 3 groups. A group of patients in the ICU in serious condition. A group with patients in the hospital but in a moderate state and a group with patients at home, with mild manifestation of the disease. We have a tool capable of predicting which individuals are at greater or lesser risk for the pandemic, and regarding vaccine risks. Discover more details at Roberto Grobman.